Expertise in
7
conditions

Dr. Sandeep Soni

Hematology | Oncology
Lucile Packard Children's Hospital Stanford
725 Welch Rd, 
Palo Alto, CA 
Clinical Trials:Currently Recruiting for 1 Trial
Expertise in
7
conditions
Lucile Packard Children's Hospital Stanford
725 Welch Rd, 
Palo Alto, CA 

Overview

Sandeep Soni is a Hematologist and an Oncologist in Palo Alto, California. Dr. Soni is highly rated in 7 conditions, according to our data. His top areas of expertise are Hemoglobinopathy, Beta Thalassemia, Congenital Hemolytic Anemia, Anemia, and Bone Marrow Transplant.

His clinical research consists of co-authoring 20 peer reviewed articles and participating in 4 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Hematology
Oncology

Licenses

Pediatric Hematology-Oncology in OH

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Locations

Lucile Packard Children's Hospital Stanford
725 Welch Rd, Palo Alto, CA 94304

Additional Areas of Focus

Dr. Soni has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.

Immune Thrombocytopenic Purpura (ITP)

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) for Transplantation in Pediatric and Adult Patients With Hematologic Malignancies and Other Indications
Enrollment Status: Recruiting
Publish Date: February 11, 2026
Intervention Type: Drug
A Phase 2 Clinical Trial to Evaluate the Efficacy of the Infusion of Autologous CD34+ Cells Transduced With a Lentiviral Vector Carrying the FANCA Gene in Pediatric Subjects With Fanconi Anemia Subtype A
A Phase 2 Clinical Trial to Evaluate the Efficacy of the Infusion of Autologous CD34+ Cells Transduced With a Lentiviral Vector Carrying the FANCA Gene in Pediatric Subjects With Fanconi Anemia Subtype A
Enrollment Status: Active_not_recruiting
Publish Date: December 22, 2025
Intervention Type: Biological
Study Drug: RP-L102 CD34-Enriched Cells
Study Phase: Phase 2
Gene Therapy for Pyruvate Kinase Deficiency (PKD): A Phase I Clinical Trial to Evaluate the Safety of the Infusion of Autologous CD34+ Cells Transduced With a Lentiviral Vector Carrying the Codon Optimized Red Cell Pyruvate Kinase (coRPK) Gene in Adult and Pediatric Subjects With PKD
Gene Therapy for Pyruvate Kinase Deficiency (PKD): A Phase I Clinical Trial to Evaluate the Safety of the Infusion of Autologous CD34+ Cells Transduced With a Lentiviral Vector Carrying the Codon Optimized Red Cell Pyruvate Kinase (coRPK) Gene in Adult and Pediatric Subjects With PKD
Enrollment Status: Completed
Publish Date: September 05, 2025
Intervention Type: Biological
Study Drug: RP-L301
Study Phase: Phase 1
A Phase I Clinical Trial to Evaluate the Safety of the Infusion of Autologous CD34+ Cells Transduced With a Lentiviral Vector Carrying the FANCA Gene in Pediatric Subjects With Fanconi Anemia Subtype A
A Phase I Clinical Trial to Evaluate the Safety of the Infusion of Autologous CD34+ Cells Transduced With a Lentiviral Vector Carrying the FANCA Gene in Pediatric Subjects With Fanconi Anemia Subtype A
Enrollment Status: Unknown
Publish Date: November 24, 2020
Intervention Type: Biological
Study Drug: RP-L102
Study Phase: Phase 1
View 3 Less Clinical Trials

20 Total Publications

The role of the conditioning regimen for autologous and ex vivo genetically modified hematopoietic stem cell-based therapies: recommendations from the ISCT stem cell engineering committee.
The role of the conditioning regimen for autologous and ex vivo genetically modified hematopoietic stem cell-based therapies: recommendations from the ISCT stem cell engineering committee.
Journal: Cytotherapy
Published: June 28, 2024
Similar Doctors
Expertise in
14
conditions
Dr. Elliott Vichinsky
Hematology | Oncology
Expertise in
14
conditions
Dr. Elliott Vichinsky
Hematology | Oncology

UCSF Benioff Children's Hospital Oakland

747 52nd St, 
Oakland, CA 
 (28.1 miles away)
510-428-3372
Languages Spoken:
English
See accepted insurances

Elliott Vichinsky is a Hematologist and an Oncologist in Oakland, California. Dr. Vichinsky is highly rated in 14 conditions, according to our data. His top areas of expertise are Congenital Hemolytic Anemia, Hemoglobinopathy, Hemolytic Anemia, Splenectomy, and Bone Marrow Transplant.

Expertise in
12
conditions
Dr. Ashutosh Lal
Hematology | Oncology
Expertise in
12
conditions
Dr. Ashutosh Lal
Hematology | Oncology

UCSF Benioff Children's Hospital Oakland

747 52nd St, 
Oakland, CA 
 (28.1 miles away)
510-428-3374
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Ashutosh Lal is a Hematologist and an Oncologist in Oakland, California. Dr. Lal is highly rated in 12 conditions, according to our data. His top areas of expertise are Thalassemia, Beta Thalassemia, Congenital Hemolytic Anemia, Hemoglobinopathy, and Splenectomy.

Expertise in
11
conditions
Dr. Mark Walters
Hematology | Oncology
Expertise in
11
conditions
Dr. Mark Walters
Hematology | Oncology

UCSF Benioff Children's Hospital Oakland

747 52nd St, 
Oakland, CA 
 (28.1 miles away)
510-428-3374
Languages Spoken:
English
See accepted insurances

Mark Walters is a Hematologist and an Oncologist in Oakland, California. Dr. Walters is highly rated in 11 conditions, according to our data. His top areas of expertise are Hemoglobinopathy, Sickle Cell Disease, Congenital Hemolytic Anemia, Hemolytic Anemia, and Bone Marrow Transplant.

Frequently Asked Questions about Dr. Sandeep Soni

How do I make an appointment with Dr. Sandeep Soni?

You can book an appointment with Dr. Sandeep Soni by calling their office at 650-497-8000. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Sandeep Soni a top-rated expert for Hemoglobinopathy?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Sandeep Soni is classified as an Distinguished expert for Hemoglobinopathy, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Sandeep Soni specialize in?

While Dr. Sandeep Soni is a Hematology, they have specific expertise in Hemoglobinopathy, Beta Thalassemia, and Congenital Hemolytic Anemia. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Sandeep Soni participate in research or clinical trials?

Yes. Dr. Sandeep Soni has published 20 articles and abstracts on conditions like Hemoglobinopathy. You can view a list of Dr. Sandeep Soni's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Soni's expertise for a condition
ConditionClose
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile